Full name
CLINICAL RESEARCH CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.75.Z - Retail sale of cosmetics and toiletries
58.12.Z - Publishing of newspapers
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -2,4 | -3,5 | -52,2 | -1387,3 |
EBITDA | -3 | -2,1 | -47,6 | -2203,9 |
Short time liabilities | 39,2 | 1,8 | 32,1 | 1685,7 |
Equity capital | -13,4 | -16,8 | -68,9 | -311,1 |
Operating profit (EBIT) | -3 | -2,1 | -47,6 | -2203,9 |
Assets | 26,8 | 25,5 | 79,2 | 210,7 |
Net profit (loss) | -2,4 | -3,5 | -52,2 | -1387,3 |
Cash | 1,5 | 0,6 | 32 | 5490,8 |
Net income from sale | 9,6 | 11,2 | 160,2 | 1337,1 |
Liabilities and provisions for liabilities | 40,2 | 42,3 | 148,1 | 250,5 |
Working assets | 26 | 24,7 | 78,4 | 217,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 18 | 20,9 | 75,7 | 54,8 |
Equity capital to total assets | -49,8 | -65,8 | -87,1 | -21,3 |
Gross profit margin | -25 | -31,5 | -32,6 | -1,1 |
EBITDA Margin | -30,8 | -18,5 | -29,7 | -11,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 1490 | 59 | 73 | 14 |
Current financial liquidity indicator | 0.647725522518158 | 8.819788932800293 | 2.297050952911377 | -6,5 |
Net dept to EBITDA | -12.345985412597656 | -18.806869506835938 | -1.7219107151031494 | 17,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane